Antibody to the dendritic cell surface activation antigen CD83 prevents acute graft-versus-host disease.

J Exp Med · 2009 · PMC2646577 · PMID 19171763

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

TNF and IL-5 concentrations were also reduced by alemtuzumab treatment (P < 0.05), but any reductions caused by RA83 did not reach statistical significance ( Fig. 4 e ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.